Published : Nov-2017
No. of Pages : 36
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Artificial Lung Overview 5
3 Products under Development 6
3.1 Artificial Lung - Pipeline Products by Stage of Development 6
3.2 Artificial Lung - Pipeline Products by Territory 7
3.3 Artificial Lung - Pipeline Products by Regulatory Path 8
3.4 Artificial Lung - Pipeline Products by Estimated Approval Date 9
3.5 Artificial Lung - Ongoing Clinical Trials 10
4 Artificial Lung - Pipeline Products under Development by Companies 11
4.1 Artificial Lung Companies - Pipeline Products by Stage of Development 11
4.2 Artificial Lung - Pipeline Products by Stage of Development 12
5 Artificial Lung Companies and Product Overview 13
5.1 ALung Technologies Inc Company Overview 13
5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Breethe, Inc. Company Overview 17
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Case Western Reserve University Company Overview 18
5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Haemair Ltd Company Overview 19
5.4.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Lung Biotechnology PBC Company Overview 20
5.5.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 McGowan Institute for Regenerative Medicine Company Overview 21
5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 MedArray Inc. Company Overview 23
5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Michigan Critical Care Consultants, Inc. Company Overview 24
5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 Miromatrix Medical Inc Company Overview 25
5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 The Charles Stark Draper Laboratory Inc Company Overview 26
5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 University of California San Francisco Company Overview 27
5.11.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 University of Pittsburgh Company Overview 28
5.12.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 Xenios AG Company Overview 29
5.13.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 29
6 Artificial Lung- Recent Developments 31
6.1 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market 31
6.2 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS 32
7 Appendix 33
7.1 Methodology 33
7.2 About GlobalData 36
7.3 Contact Us 36
7.4 Disclaimer 36
1.1 List of Tables
Table 1: Artificial Lung - Pipeline Products by Stage of Development 6
Table 2: Artificial Lung - Pipeline Products by Territory 7
Table 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Table 5: Artificial Lung - Ongoing Clinical Trials 10
Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development 11
Table 7: Artificial Lung - Pipeline Products by Stage of Development 12
Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: Hemolung RAS - Product Status 13
Table 10: Hemolung RAS - Product Description 13
Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview 14
Table 12: Hemolung RAS - A Pivotal Clinical Study of Hemolung Respiratory Assist System in Treatment of Patients with Chronic Obstructive Pulmonary Disease 15
Table 13: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support 15
Table 14: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 15
Table 15: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 16
Table 16: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 16
Table 17: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: OXY-1 - Product Status 17
Table 19: OXY-1 - Product Description 17
Table 20: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: Portable Artificial Lung - Product Status 18
Table 22: Portable Artificial Lung - Product Description 18
Table 23: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: Portable Artificial Lung - Product Status 19
Table 25: Portable Artificial Lung - Product Description 19
Table 26: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: Implantable Artificial Lung - Product Status 20
Table 28: Implantable Artificial Lung - Product Description 20
Table 29: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: Biohybrid Artificial Lung - Product Status 21
Table 31: Biohybrid Artificial Lung - Product Description 21
Table 32: Chronic Artificial Lung - Product Status 22
Table 33: Chronic Artificial Lung - Product Description 22
Table 34: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 35: Artificial Lung Fiber - Product Status 23
Table 36: Artificial Lung Fiber - Product Description 23
Table 37: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 38: BioLung - Product Status 24
Table 39: BioLung - Product Description 24
Table 40: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 41: Miromatrix Artificial Lung - Product Status 25
Table 42: Miromatrix Artificial Lung - Product Description 25
Table 43: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 44: Silicone-Based Microfluidic Artificial Lung - Product Status 26
Table 45: Silicone-Based Microfluidic Artificial Lung - Product Description 26
Table 46: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
Table 47: Neonatal ECMO Device - Product Status 27
Table 48: Neonatal ECMO Device - Product Description 27
Table 49: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 28
Table 50: Paracorporeal Ambulatory Assist Lung - Product Status 28
Table 51: Paracorporeal Ambulatory Assist Lung - Product Description 28
Table 52: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 29
Table 53: i-lung - Product Status 29
Table 54: i-lung - Product Description 29
Table 55: Xtralung - Product Status 30
Table 56: Xtralung - Product Description 30
Table 57: Glossary 35
1.2 List of Figures
Figure 1: Artificial Lung - Pipeline Products by Stage of Development 6
Figure 2: Artificial Lung - Pipeline Products by Territory 7
Figure 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Figure 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Figure 5: Artificial Lung - Ongoing Clinical Trials 10
